Term
|
Definition
| White blood cells belonging to the specific immune system. |
|
|
Term
|
Definition
| They can be recognized and bound by antibodies. |
|
|
Term
|
Definition
| A condition in which the numbers of circulating red blood cells are reduced, or their content of hemoglobin is inadequate, reducing the oxygen carrying capacity of blood. |
|
|
Term
|
Definition
| A genetic disease in which the synthesis of hemoglobin may be impaired. |
|
|
Term
|
Definition
| The chemical agents of the specific immune system. |
|
|
Term
|
Definition
| Clumping of the transfused red cells caused by antibody binding. |
|
|
Term
|
Definition
| For these antigens, one’s body automatically possesses antibodies against those antigens that one’s own blood cells do not possess. |
|
|
Term
|
Definition
| A greenish yellow pigment that results from the conversion of hemoglobin released in the course of destruction of red blood cells. |
|
|
Term
|
Definition
| The result of gradual contraction of the fibrin threads that make up the clot. |
|
|
Term
|
Definition
| The ability of blood to clot. |
|
|
Term
|
Definition
| The mechanism of generation of interstitial fluid from plasma. |
|
|
Term
|
Definition
| A series of plasma proteins involved in hemostasis that form fibrin from the plasma protein fibrinogen at the site of an injury. |
|
|
Term
|
Definition
| A more permanent plug, or thrombus, produced during the process of hemostasis. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| A condition in which the destruction of mature red cells causes a form of hemolytic anemia marked by the appearance of immature, nucleated red cells in the newborn’s blood. |
|
|
Term
|
Definition
| A plasma protein specifically involved in forming blood clots. |
|
|
Term
|
Definition
| In hemostasis, the pathway initiated by chemical factors released by damaged cells, and involves activation of Factor VII leading to activation of Factor X and association of Factor X and Factor V to form a prothrombin activator complex. |
|
|
Term
| Erythrocyte sedimentation rate |
|
Definition
| The rate at which the red cells fall to the bottom of a tube of blood simply through the effect of gravity. |
|
|
Term
|
Definition
| Clot breakdown in the healing process. |
|
|
Term
|
Definition
| A hormone responsive to the oxygenation state of tissues that influences the formation of red cells. |
|
|
Term
|
Definition
| A fraction of the globulins that consists specifically of antibodies, a major type of recognition protein of the immune system. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Cells, although most of them (the red blood cells) lack a nucleus, that sink to the bottom of the centrifuge tube, if a sample of blood is centrifuged. |
|
|
Term
|
Definition
| White blood cells that are agents of the nonspecific immune system. |
|
|
Term
|
Definition
| The stem cell for all blood cell types. |
|
|
Term
|
Definition
| The pigment that gives blood its red color. |
|
|
Term
|
Definition
| An excess of bilirubin, giving the skin and sclera of the eyes a yellow tinge. |
|
|
Term
|
Definition
| A process that prevents or minimizes blood loss by plugging injured vessels until healing can occur. |
|
|
Term
|
Definition
| An acute loss of blood from the circulatory system. |
|
|
Term
|
Definition
| Anemias in which the rate of destruction of red cells may be increased. |
|
|
Term
|
Definition
| The fraction of blood volume occupied by red cells. |
|
|
Term
|
Definition
| The pathway initiated by trauma to the blood itself or by exposure to an abnormal surface, such as glass or collagen, leads to a cascade of factors that terminates in the formation of the prothrombin activator complex. |
|
|
Term
|
Definition
| Agranular lymphocytes that leave the circulation and enter tissues where they transform into macrophages. |
|
|
Term
|
Definition
| The cells of the specific immune system, which is able to identify and direct an attack against foreign substances, microbial invaders, and other nonself materials that the body has met with previously. |
|
|
Term
|
Definition
| An excess of bilirubin, giving the skin and sclera of the eyes a yellow tinge. |
|
|
Term
|
Definition
| A large nucleated cell involved in the genesis of platelets. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Scavenger cells that phagocytize dead cells, bacteria, and other foreign materials. |
|
|
Term
|
Definition
| A genetic disease in which the synthesis of hemoglobin may be impaired. |
|
|
Term
|
Definition
| An inactive plasma protein that is incorporated into clots to digest fibrin. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| An excess of red blood cells. |
|
|
Term
|
Definition
| The smallest of the formed elements, only 1–2 microns in diameter. They are the cellular component of the process of hemostasis. |
|
|
Term
|
Definition
| A component of the blood. |
|
|
Term
|
Definition
| The clear straw-colored fluid component of blood, consisting of about 92 percent water, about 7 percent protein, and about 1 percent salts, of which the major one is NaCl. It also contains various materials being transported, including the gases O2 and CO2, nutrients, wastes, and hormones. |
|
|
Term
|
Definition
| A reaction to a transfusion of blood that occurs between genetically different individuals. |
|
|
Term
|
Definition
| Resulting from the removal of the proteins involved in clotting, it is a more stable form of plasma that may be used medicinally as a source of gamma globulins. |
|
|
Term
|
Definition
| A second form of blood type. Roughly one-sixth of the U.S. population lacks the Rh antigen (is Rh negative), and therefore is able to mount a primary immune response against it. By itself, this fact is not different from the situation with many other blood group antigens. However, the antiRh antibody, like many other antibodies present in the mother’s blood, can cross the placental barrier between mother and fetus and attack fetal red cells. |
|
|
Term
|
Definition
| A genetic disease in which the synthesis of hemoglobin may be impaired. |
|
|
Term
|
Definition
| The ratio between the weight of the liquid and that of an equal volume o |
|
|
Term
|
Definition
| A preparation of antiRh antibodies that prevents erythroblastosis. |
|
|
Term
|
Definition
| A measure of the fluid’s resistance to flow. |
|
|
Term
|
Definition
| A plasma protein that converts fibrinogen into fibrin. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Chemical factors released by damaged cells that initiate the extrinsic pathway. |
|
|
Term
|
Definition
| A component of blood that includes granulocytes and agranular leukocytes. |
|
|
